Core

<div class="textg" style="text-align: justify; font-weight: lighter; line-height: 1.3em; font-size: 15px; border-radius: 3px; color: #80909a; padding: 10px; background-color: #F4F6F9; margin-bottom: 15px;">
 Neither the author, Tim Fries, nor this website, The Tokenist, provide financial advice. Please consult our&nbsp;<a href="https://tokenist.com/terms-of-service/" style="text-decoration:underline;color:#3c7b7b" target="_blank" rel="noreferrer noopener" class="deco-link">website policy</a>&nbsp;prior to making financial decisions.
</div> 
<p class="has-drop-cap">Danaher Corporation (NYSE: DHR), a global leader in the life sciences and diagnostics sectors, has reported its <a href="https://investors.danaher.com/quarterly-earnings?cat=24" target="_blank" aria-label="financial results (opens in a new tab)" rel="noreferrer noopener nofollow" class="deco-link">financial results</a> for the first quarter ended March 29, 2024. <br><br>Despite a challenging economic environment, the company surpassed expectations in terms of revenue and earnings. Danaher announced net earnings of $1.1 billion, translating to $1.45 per diluted common share. The non-GAAP diluted net earnings per common share stood at $1.92 on an adjusted basis. This performance is particularly noteworthy given the reported revenue decrease of 2.5% year-over-year to $5.8 billion, with non-GAAP core revenue decreasing by 4.0%.</p> 
<p>Operating cash flow remained robust at $1.7 billion, with non-GAAP free cash flow reaching $1.4 billion. The company’s President and Chief Executive Officer, Rainer M. Blair, expressed satisfaction with the quarter’s results, highlighting the improved order trends in the bioprocessing business and market share gains in the molecular diagnostics business at Cepheid. <br><br>Blair emphasized the combination of Danaher’s leading portfolio and the execution of the Danaher Business System as foundational elements for sustained long-term performance and significant contributions to improving human health.</p> 
<h3 id="danaher-comfortably-beats-eps-and-revenue-expectations-in-q1">Danaher Comfortably Beats EPS and Revenue Expectations in Q1</h3> 
<p>Analysts had projected earnings per share (<a href="https://tokenist.com/investing/how-to-value-a-stock/" rel="dofollow" class="deco-link">EPS</a>) of $1.72 and revenue of $5.62 billion for the quarter. Danaher’s adjusted EPS of $1.92 significantly exceeded these expectations, showcasing the company’s operational efficiency and ability to generate higher profitability than anticipated. <br><br>Similarly, the reported revenue of $5.8 billion surpassed analyst forecasts, indicating more robust sales performance across its diverse portfolio. Despite a year-over-year revenue decline, these results underscore Danaher’s resilience and strategic focus in a competitive landscape.</p> 
<p>Better-than-expected financial outcomes can be attributed to several factors, including strong performance in key business segments and effective cost management. The company’s ability to adapt to changing market conditions and leverage the Danaher Business System has enabled it to continue delivering value to shareholders and customers. </p> 
<div class="cta-referral"> 
 <img src="https://tokenist.com/wp-content/themes/thetokenist/assets/img/del/cta-referral-1.png" alt="" class="cta-referral__img" loading="lazy" decoding="async"> 
 <div class="cta-referral__text"> 
  <p>Join our&nbsp;<a href="https://t.me/thetokenist" target="_blank" rel="noreferrer noopener nofollow" class="deco-link">Telegram group&nbsp;and never miss a breaking story.</a></p> 
 </div> 
</div> 
<h3 id="cautious-guidance-expects-non-gaap-core-revenue-to-decline-in-q2">Cautious Guidance, Expects Non-GAAP Core Revenue to Decline in Q2 </h3> 
<p>Looking ahead, Danaher guided for the second quarter and full year 2024, with expectations set against ongoing global economic uncertainty.<br><br>For the second quarter of 2024, the company anticipates a mid-single-digit decline in non-GAAP core revenue year over year and a low-single-digit decline for the full year. This guidance reflects the company’s cautious outlook in light of potential market volatility and challenges within the global economic environment.</p> <iframe src="https://tokenist.substack.com/embed" width="100%" height="320" style="border:1px solid #EEE; background:white;" frameborder="0" scrolling="no"></iframe> 
<p><em>Disclaimer: The author does not hold or have a position in any securities discussed in the article.</em></p> 
<h3 id="br"><br></h3> 
<p>The post <a rel="nofollow" href="https://tokenist.com/danaher-dhr-beats-q1-projections-with-1-1-b-in-net-earnings-1-92-eps/">Danaher (DHR) Beats Q1 Projections with $1.1 B in Net Earnings, $1.92 EPS</a> appeared first on <a rel="nofollow" href="https://tokenist.com">Tokenist</a>.</p>

Danaher (DHR) Beats Q1 Projections with $1.1 B in Net Earnings, $1.92 EPS

Table of Contents

Tokenist

Other articles published on Apr 23, 2024

Crypto Venture Capitalists Pump $12 Million into Shiba Inu’s New Blockchain and the TREAT Token

Top 5 Cryptocurrencies Under $1 for 3000% Growth in 2024

XRP News: 3 Reasons Why XRP Price Could Skyrocket In 2024

Bitcoin Accumulates Post-Halving: Here’s Why This is a Huge Bullish Signal

Top 5 Solana Ecosystem Coins to look out this 2024

Key Crypto Events Including Shiba Inu $12M Fund Raise, OKX Listing And More

Join our free newsletter for daily crypto updates!